Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
LG Chem will receive totaling up to $95.5 million for the China rights
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated
